Villwock Mark R, Singla Amit, Padalino David J, Deshaies Eric M
Department of Neurosurgery, State University of New York Upstate Medical University, Syracuse, New York.
Department of Neurosurgery, State University of New York Upstate Medical University, Syracuse, New York.
J Stroke Cerebrovasc Dis. 2014 Oct;23(9):2341-9. doi: 10.1016/j.jstrokecerebrovasdis.2014.05.003. Epub 2014 Sep 6.
The factors influencing outcomes after emergent admission for symptomatic carotid artery stenosis treated with revascularization by endarterectomy or stenting are yet to be fully elucidated.
We analyzed revascularization of carotid artery stenosis for patients admitted emergently using the Nationwide Inpatient Sample (2008-2011). Admission characteristics, economic measures, in-hospital mortality, and iatrogenic stroke were compared between (1) endarterectomy and stenting, (2) patients with and without cerebral infarction, and (3) ultra-early (within 48 hours of admission) and deferred (up to 2 weeks) intervention.
72,797 admissions meeting our inclusion criteria were identified. Factors associated with ultra-early revascularization were male patients, low comorbidity burden, stenosis without infarction, and stenting. Ultra-early intervention significantly decreased cost and length of stay, and stenting for patients without infarction decreased length of stay but increased cost. Patients without infarction treated within 48 hours had significantly lower mortality and iatrogenic stroke rate. Patients with infarction receiving ultra-early revascularization had increased odds of mortality and iatrogenic stroke in comparison with the deferred group. Patients with infarction receiving stenting experienced increased odds of mortality in comparison with those receiving endarterectomy, but there was no significant difference in iatrogenic stroke rate. Recombinant tissue plasminogen activator (rtPA) administration on the day of revascularization greatly increased the odds of iatrogenic stroke and mortality.
Larger prospectively randomized trials evaluating the optimum timing of revascularization after emergent admission of carotid artery stenosis seem warranted.
对于因有症状的颈动脉狭窄而紧急入院并接受内膜切除术或支架置入术进行血运重建治疗后的预后影响因素,目前尚未完全阐明。
我们使用全国住院患者样本(2008 - 2011年)分析了紧急入院患者的颈动脉狭窄血运重建情况。比较了以下几方面的入院特征、经济指标、院内死亡率和医源性卒中:(1)内膜切除术和支架置入术;(2)有和没有脑梗死的患者;(3)超早期(入院后48小时内)和延期(最长2周)干预。
确定了72797例符合我们纳入标准的入院病例。与超早期血运重建相关的因素为男性患者、低合并症负担、无梗死的狭窄以及支架置入术。超早期干预显著降低了费用和住院时间,对于无梗死的患者,支架置入术虽增加了费用但缩短了住院时间。在48小时内接受治疗的无梗死患者的死亡率和医源性卒中发生率显著更低。与延期治疗组相比,接受超早期血运重建的梗死患者的死亡和医源性卒中几率增加。与接受内膜切除术的患者相比,接受支架置入术的梗死患者的死亡几率增加,但医源性卒中发生率无显著差异。在血运重建当天给予重组组织型纤溶酶原激活剂(rtPA)极大地增加了医源性卒中和死亡的几率。
似乎有必要开展更大规模的前瞻性随机试验,以评估颈动脉狭窄紧急入院后血运重建的最佳时机。